Form 4: CME Group Director Equity Transactions
Statement of Changes in Beneficial Ownership
Harold Eugene Ford Jr. reports transactions involving CME Group Inc. Class A Common Stock, including grants and shares issued in lieu of director fees.
Summary
- Harold Eugene Ford Jr., a Director at CME Group Inc., has reported transactions related to Class A Common Stock.
- These transactions include the acquisition of 645 shares under the annual equity compensation program for non-employee directors, which are fully vested and not subject to further vesting conditions.
- Additionally, 422 shares were acquired in lieu of a portion of the annual cash retainer for serving on the Board of Directors, with the number of shares determined by dividing the retainer by the closing stock price on the grant date.
- Following these transactions, Ford beneficially owns 1,736 shares directly and 2,158 shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine director compensation transactions and does not contain new strategic information or significant financial performance data.
Positives
- Director Ford received fully vested shares as part of the annual equity compensation, indicating continued incentive alignment.
- The company utilizes a mechanism to issue stock in lieu of cash retainers, potentially conserving cash while aligning director interests with shareholders.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details past transactions.
Industry Context
StockSavvy.ai notes that this filing is a standard Form 4 disclosure, reflecting typical compensation practices for non-employee directors in the financial exchange industry, where equity awards are common to align director interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The transactions reflect standard director compensation practices, aligning director interests with the company's performance through equity ownership.
Key Dates
| Date | Description |
|---|---|
| 06/25/2026 | Earliest transaction date and transaction date for acquisition of Class A Common Stock. |
| 06/29/2026 | Date of signature for the filing. |
| 05/06/2026 | Date of execution for the Power of Attorney. |
Keywords
CME Group, Form 4, Director Compensation, Equity Grant, Class A Common Stock, Beneficial Ownership, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.